No Data
US Stock MarketDetailed Quotes
NVAX Novavax
Watchlist
7.195
+0.085+1.20% Trading 09/27 15:07 ET
7.380High7.025Low3.15MVolume
7.180Open7.110Pre Close22.70MTurnover3.56%Turnover RatioLossP/E (TTM)726.01MMarket Cap25.66052wk HighLossP/E (Static)100.90MShares5.60552wk Low-0.96P/B636.99MFloat Cap331.680Historical High--Dividend TTM88.53MShs Float3.540Historical Low--Div YieldTTM4.99%Amplitude7.199Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Novavax Company
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Revenue Breakdown
Business
Unit:USD
12/31/2022
Stock NameRevenueRatio
Product sales1.55B78.46%
Grants382.92M19.32%
Royalties and other43.99M2.22%
News
Novavax, Inc.'s (NASDAQ:NVAX) Latest 7.4% Decline Adds to One-year Losses, Institutional Investors May Consider Drastic Measures
To get a sense of who is truly in control of Novavax, Inc. (NASDAQ:NVAX), it is important to understand the ownership structure of the business.
Updated COVID Boosters to Divide America
Two new national polls indicate a mixed reaction with a partisan divide among Americans on the need for updated COVID boosters that the U.S. regulators recently cleared for a fall immunization drive.
Novavax to Get European Watchdog's Ruling on Updated COVID Vaccine Use in October
The European Medicines Agency is poised to rule on the use of Novavax's (NVV1.F) updated COVID-19 vaccine in October, Reuters reported Thursday, citing a statement by the agency's director Emer Cooke.
Comments
$Novavax(NVAX.US$ Everything is oversold. This counter included. One day, short sellers will be caught by surprise but as of now, they are having a field day.
1
$Pfizer(PFE.US$$BioNTech(BNTX.US$$Moderna(MRNA.US$$Axcella Health(AXLA.US$$Novavax(NVAX.US$ Government COVID-19 vaccines promo has begun.
2
1
1
1
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--